CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
暂无分享,去创建一个
Jussi Jokinen | Björn Mårtensson | A. Nordström | J. Jokinen | B. Mårtensson | Anna-Lena Nordström | Peter Nordström | P. Nordström
[1] F. Holsboer,et al. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression , 2005, Biological Psychiatry.
[2] W. Coryell,et al. Hyperactivity of the hypothalamic–pituitary–adrenal axis and mortality in major depressive disorder , 2006, Psychiatry Research.
[3] M. Åsberg,et al. Survival analysis of suicide risk after attempted suicide , 1995, Acta psychiatrica Scandinavica.
[4] C. Alling,et al. Prediction of Suicidal Behavior from Biologic Tests , 1992, Journal of clinical psychopharmacology.
[5] G. Isacsson. Depression is the core of suicidality – its treatment is the cure , 2006, Acta psychiatrica Scandinavica.
[6] M. Linnoila,et al. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. , 1989, Archives of general psychiatry.
[7] J. Mann,et al. Can biological tests assist prediction of suicide in mood disorders? , 2006, The international journal of neuropsychopharmacology.
[8] G. Keitner,et al. The dexamethasone suppression test and completed suicide , 1990, Acta psychiatrica Scandinavica.
[9] Jamie D. Feusner,et al. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. , 2004, Journal of affective disorders.
[10] S. Dahl,et al. Clinical Pharmacology in Psychiatry , 1981, Palgrave Macmillan UK.
[11] A. Young,et al. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin , 1998, Psychological Medicine.
[12] D. Lester,et al. The Concentration of Neurotransmitter Metabolites in the Cerebrospinal Fluid of Suicidal Individuals: a Meta-Analysis , 1995, Pharmacopsychiatry.
[13] F. Chaouloff. Physiopharmacological interactions between stress hormones and central serotonergic systems , 1993, Brain Research Reviews.
[14] Å. Westrin,et al. The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters , 2003, European Psychiatry.
[15] F. Chaouloff. Serotonin, stress and corticoids , 2000, Journal of psychopharmacology.
[16] A. Young,et al. Corticosteroid-serotonin interactions in depression: a review of the human evidence , 2004, Psychopharmacology.
[17] Lisa J. Martin,et al. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid , 2004, Biological Psychiatry.
[18] M. Åsberg,et al. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.
[19] W. Coryell,et al. The dexamethasone suppression test and suicide prediction. , 2001, The American journal of psychiatry.
[20] A. Nordström,et al. CSF 5‐HIAA, suicide intent and hopelessness in the prediction of early suicide in male high‐risk suicide attempters , 2006, Acta psychiatrica Scandinavica.
[21] O. Meijer,et al. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. , 1998, Critical reviews in neurobiology.
[22] M. Åsberg,et al. CSF 5-HIAA predicts suicide risk after attempted suicide. , 1994, Suicide & life-threatening behavior.
[23] M. Oquendo,et al. Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? , 2006, Acta psychiatrica Scandinavica.
[24] F. Keller,et al. Red-cell and serum folate levels in depressed inpatients who commit violent suicide: a comparison with control groups. , 1995, Pharmacopsychiatry.